Literature DB >> 7674383

Effects of inhaled nitric oxide on right ventricular function in endotoxin shock.

P J Offner1, H Ogura, B S Jordan, B A Pruitt, W G Cioffi.   

Abstract

Sepsis has been shown to cause right ventricular (RV) dysfunction, which may be related to pulmonary hypertension and increased RV afterload. This study evaluates the effects of inhaled nitric oxide (NO), a selective pulmonary vasodilator, on RV function in a porcine model of endotoxemia. After an infusion of Escherichia coli lipopolysaccharide (LPS; 200 micrograms/kg), animals were resuscitated with saline (1 mL/kg/min) and observed for 3 hours while being mechanically ventilated (Fio2 = 0.6, tidal volume = 12 mL/kg, and peak end-expiratory pressure = 5 cm H2O). The LPS group (n = 5) received no additional treatment. The NO group (n = 5) received inhaled NO (40 ppm) for the last 2 hours. The control group (n = 5) received only saline without LPS. Hemodynamic data and blood gases were collected hourly for 3 hours. LPS resulted in pulmonary hypertension and RV dysfunction as indexed by a decreased RV ejection fraction and increased RV end-diastolic volume. Inhaled NO significantly decreased pulmonary hypertension and significantly increased RV ejection fraction and oxygen delivery without adverse effects. In conclusion, inhaled NO significantly improved pulmonary hypertension and RV dysfunction in a porcine model of endotoxemia and should be a useful therapeutic modality in selected septic patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674383     DOI: 10.1097/00005373-199508000-00001

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  2 in total

Review 1.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

2.  Right Ventricle Failure in Sepsis: A Case Report.

Authors:  Umashankar Lakshmanadoss; Bryana M Levitan; David H Hsi
Journal:  Cardiol Res       Date:  2011-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.